Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis

Journal of Rheumatology

Volumn 27, Issue 12, 2000, Pages 2838-2842

  Sato, S ^a   Hanakawa, H ^a   Hasegawa, M ^a   Nagaoka, T ^a   Hamaguchi, Y ^a   Nishijima, C ^a   Komatsu, K ^a   Hirata, A ^a   Takehara, K ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 12; Renal vascular damage; Systemic sclerosis; Type I helper T cell

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TH1 CELL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; INTERLEUKIN-12; KIDNEY DISEASES; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TH1 CELLS;

EID: 0033673989     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations
2. Early phenotypic activation of circulating helper memory T cells in scleroderma: Correlation with disease activity
3. Sequential dermal microvascular and perivascular changes in the development of scleroderma
4. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization
5. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
6. Interleukin-12 and its role in the generation of TH1 cells
7. The interleukin-12/interleukin-12 receptor system: Role in normal and pathologic immune responses
8. Identification and purification of natural killer cell stimulatory factor, a cytokine with multiple biologic effects on human lymphocytes
9. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
10. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1 and Th2 derived cytokines
11. Expression of interferon-γ, IL-10, IL-12 and transforming growth factor-β mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
13. Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis
14. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis
15. Antihistone antibodies in systemic sclerosis: Association with pulmonary fibrosis
16. Unusual causes of increased vascular impedance in renal transplants: Duplex Doppler evaluation
17. Enhanced production of interleukin-2 in patients with progressive systemic sclerosis. Hyperactivity of CD4-positive T cells?
18. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
19. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor-α, and interferon-γ levels in sera from patients with scleroderma
20. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor βI
21. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis
22. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts
23. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis
24. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis
25. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
26. Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study
27. Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy
28. Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis
29. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
30. Inhibition of angiogenesis in vivo by interleukin 12